v3.26.3
Segments - Schedule of Other Financial Information Regarding The Company’s Operating Segment (Details) - Operating Segment [Member] - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Operating expenses:        
Research personnel compensation costs, including stock-based compensation $ 95 $ 287 $ 681 $ 945
Contract research organization and regulatory costs 39 315 1,105 315
Administrative personnel compensation costs, including stock-based compensation 895 4,126 2,247 4,861
Rent and office costs 50 97 273 415
Legal and accounting costs 931 976 2,530 1,625
Transaction costs [1] 2,798 15,060 2,798 15,060
Other expenses [2] 45 848 1,770 915
Total segment expenses 4,853 21,709 11,404 24,136
Loss from operations (4,853) (21,709) (11,404) (24,136)
Other income (expenses)        
Gain (loss) on change in the fair value of convertible notes 7,351 (3,640) 2,303 (3,950)
Gain on change in fair value of warrant liabilities 2 884 678 884
Loss on disposal of digital assets (295)
Loss on change in fair value of digital assets (28) (28)
Interest expense (including related parties amounts of $4 and $97 for the three months ended September 30, 2026 and 2025, respectively, and $14 and $1,326 for the nine months ended September 30, 2026 and 2025, respectively) (22) (169) (61) (2,496)
Gain on extinguishment of PPP loan 441 1,832
Loss on extinguishment of related-party debt (7,886) (7,886)
Financing costs, net (3) (1,443) (2,473) (1,443)
Other income 20 15 145 15
Total other expense, net (97) (4,381) (5,757) (7,018)
Net loss $ (4,950) $ (26,090) $ (17,161) $ (31,154)
[1] Transaction costs for the three and nine months ended September 30, 2026 primarily consist of transaction costs for the G3 Option Agreement. Transaction costs for the three and nine months ended September 30, 2025 primarily consist of costs incurred in connection with the Business Combination, which was accounted for as a reverse recapitalization.
[2] Other expenses includes public relations costs, insurance costs, third party professional services and consulting costs and small balances of research materials and supplies.